Trial Details

COMPLETED
Basic Information
Clinical ID c3521
Identifier NCT01912391
Trial Title Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Borderline Personality Disorder
Interventions DRUG: Selegiline|DRUG: Placebo (for Selegiline)
Participant Information
Sponsor Mood and Anxiety Research, Inc
City Fresno
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2012-10
Primary Completion Date 2015-03
Completion Date 2015-03